Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "UK Cambridge Martins LM"

From Bioblast
Line 12: Line 12:
|country=United Kingdom
|country=United Kingdom
|weblink=[http://www.mrctox.le.ac.uk/research/martinsgroup/ Martins LM]
|weblink=[http://www.mrctox.le.ac.uk/research/martinsgroup/ Martins LM]
|MiPNetLab=Martins LM, Moisoi N, Tufi R, Costa A Β 
|MiPNetLab=Martins LM, Moisoi N, Tufi R, Costa A
|Team previous=Ali Z
|Team previous=Ali Z
|info=[http://oroboros.at/index.php?id=ioc59 IOC59]
|info=[http://oroboros.at/index.php?id=ioc59 IOC59]
|keyword=Stress, Parkinson's Disease, Apoptosis, mitochondrial signalling
|keyword=Stress, Parkinson's Disease, Apoptosis, Mitochondrial Signalling
|keywords=Stress; parkinson's disease; apoptosis
|keywords=Stress; parkinson's disease; apoptosis
|Info=[http://www.oroboros.at/index.php?id=1270 UK_Leicester_MartinsLM]
|Info=[http://www.oroboros.at/index.php?id=1270 UK_Leicester_MartinsLM]
}}
}}

Revision as of 16:13, 13 March 2012